The Code Blue Pharmacist
A patient coded at my hospital without having clear guidelines about what he wanted for treatment plan. It left the hosp...
May 13, 2022
Ethically Allocating COVID-19 Drugs Via Pre-approval Access and Emergency Use Authorization
Abstract Allocating access to unapproved COVID-19 drugs available via Pre-Approval Access pathways or Emergency Use Auth...
Publish date:1st January 1970
AstaZeneca’s Vaccine Ethical Problem
Brian M. Cummings, MD and John J. Paris, SJ, PhD In The New York Times, almost overlooked amidst multiple arti...
March 29, 2021
Ethically Allocating COVID-19 Drugs Via Pre-approval Access and Emergency Use Authorization
Abstract Allocating access to unapproved COVID-19 drugs available via Pre-Approval Access pathways or Emergency Use Auth...
Publish date:1st January 1970
The Limits of Individualism: Potential Societal Harms from the EAP for Convalescent Plasma
Abstract This issue features a set of articles addressing allocation issues for drugs for COVID-19 that have not been ap...
Publish date:1st January 1970
Vaccine Approval and Public Trust: The Dynamic Factors Influencing When a COVID-19 Vaccine...
by Berklee Robins, MD, MA & Ashley Sweet, MD, MBE Vaccines are approved when it is clear that the benefits to the in...
October 14, 2020
Emergency Use Authorization for Covid-19 Vaccines: Lessons from the Past
by Dorit Reiss, PhD LLB, Art Caplan, PhD, and Working Group on Vaccine Ethics and Policy The question whether the F...
October 6, 2020
Statement of Support for the FDA
The Working Group on Compassionate Use and Preapproval Access (CUPA), a project of the NYU Grossman School of Medicine D...
September 11, 2020
Shared Decision Making with Pediatric Medications
by Amy C. Reese, Pharm.D. My pharmacy received a prescription for prednisolone solution written for a 5-year-old patient...
July 6, 2020
The COVID-19 Pandemic and the Problem of Pseudoscience
by Kiarash Aramesh M.D., Ph.D. The COVID-19 pandemic has been accompanied by a surge of pseudoscientific claims, sometim...
June 2, 2020
My Experiences with Hydroxychloroquine Urge Caution and Ethical Research into COVID19 Ther...
by Keisha Ray, Ph.D. I take the drug hydroxychloroquine, brand name Plaquenil, for an autoimmune disease. Hydroxychloroq...
April 20, 2020
The Real Question on the Hydroxychloroquine Mystery: Why are Doctors Prescribing It?
by Craig Klugman, Ph.D. On March 31, the U.S. Department of Justice put in an order for $60,000 worth of hydroxychloroqu...
April 10, 2020